Glenmark Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 06 Mar 24 | Sell₹40,298,760,871 | Glenmark Pharmaceuticals Limited | Company | 67,389,944 | ₹597.99 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Public Companies | 0 | 0% |
| Individual Insiders | 1,000 | 0.000816% |
| Institutions | 5,716,310 | 4.67% |
| General Public | 24,919,267 | 20.3% |
| Private Companies | 91,896,285 | 75% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 91,896,285 | ₹99.3b | 0% | no data | |||
| 1,750,000 | ₹1.9b | 0% | 1.31% | |||
| 1,568,647 | ₹1.7b | 0% | 0.18% | |||
| 846,779 | ₹914.6m | -16.7% | 0.74% | |||
| 563,936 | ₹609.1m | 1,590% | 0.01% | |||
| 187,791 | ₹202.8m | -1.51% | no data | |||
| 158,079 | ₹170.7m | 0% | 0.17% | |||
| 150,031 | ₹162.0m | 0% | 0.01% | |||
| 149,022 | ₹161.0m | 1.03% | no data | |||
| 67,121 | ₹72.5m | 18.4% | no data | |||
| 65,730 | ₹71.0m | 494% | 0.01% | |||
| 59,412 | ₹64.2m | 0% | no data | |||
| 40,149 | ₹43.4m | 24.3% | no data | |||
| 38,000 | ₹41.0m | 0% | no data | |||
| 34,200 | ₹36.9m | 0% | no data | |||
| 20,100 | ₹21.7m | 28.9% | 0.03% | |||
| 15,800 | ₹17.1m | 0% | 0.34% | |||
| 1,000 | ₹1.1m | 0% | no data | |||
| 948 | ₹1.0m | 0% | no data | |||
| 357 | ₹383.8k | -62.5% | no data | |||
| 153 | ₹158.8k | 0% | no data | |||
| 52 | ₹52.9k | -86.8% | no data | |||
| 3 | ₹0 | -100% | no data |